Sabine Kirchmayr-Schliesselberger
Chairman at SANOCHEMIA PHARMAZEUTIKA AG
Profile
Sabine Kirchmayr-Schliesselberger is currently the Chairman-Supervisory Board at SANOCHEMIA Pharmazeutika GmbH, Director & Professor at Institut Für Finanzrecht since 2010, and Partner at LeitnerLeitner GmbH since 2003.
Previously, she worked as a Partner at Ernst & Young LLP from 1998 to 2003 and as a Professor-Finance at Universität Salzburg from 2004 to 2010.
She received her undergraduate and doctorate degrees from the University of Innsbruck in 1991 and her graduate degree from the same university in 1989.
Sabine Kirchmayr-Schliesselberger active positions
Companies | Position | Start |
---|---|---|
SANOCHEMIA PHARMAZEUTIKA AG | Chairman | - |
Former positions of Sabine Kirchmayr-Schliesselberger
Companies | Position | End |
---|---|---|
Universität Salzburg | Corporate Officer/Principal | 01/01/2010 |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/01/2003 |
Training of Sabine Kirchmayr-Schliesselberger
University of Innsbruck | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
SANOCHEMIA Pharmazeutika GmbH
SANOCHEMIA Pharmazeutika GmbH Pharmaceuticals: MajorHealth Technology SANOCHEMIA Pharmazeutika GMBH engages in the manufacture and distribution of pharmaceutical products. It operates through the following segments: Production, Human Pharmaceuticals, Veterinary Pharmaceuticals, Research and Development, and Others. The Production segment focuses on the synthesis of active pharmaceutical substances, drug formulation and pharmaceutical production. The Human Pharmaceuticals segment comprises of diagnostic activities including products such as X-ray and magnetic resonance imaging agents. The Veterinary Pharmaceuticals segment involves in veterinary medicine production, administration, and drug development. The Research and Development segment implements clinical trials and acquires licenses for the drugs. The company was founded by Werner Josef Frantsits on November 13, 1990 and is headquartered in Vienna, Austria. | Health Technology |
- Stock Market
- Insiders
- Sabine Kirchmayr-Schliesselberger